Cargando…
Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy
BACKGROUND: Doxorubicin-induced cardiotoxicity is widely known to occur at cumulative doses exceeding 450 mg/m(2). However, very few studies have reported incidence of cardiac dysfunction in patients on chemotherapy with lower cumulative doses. To the best of our knowledge, there is no study carried...
Autores principales: | Khattry, Navin, Malhotra, Pankaj, Grover, Anil, Sharma, Suresh C, Varma, Subhash |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2902208/ https://www.ncbi.nlm.nih.gov/pubmed/20668600 http://dx.doi.org/10.4103/0971-5851.56329 |
Ejemplares similares
-
Role of acetylation in doxorubicin-induced cardiotoxicity
por: Li, Daisong, et al.
Publicado: (2021) -
Dipyridamole ameliorates doxorubicin-induced cardiotoxicity
por: Alyasiry, Esraa, et al.
Publicado: (2022) -
Association of Cardiotoxicity With Doxorubicin and Trastuzumab: A Double-Edged Sword in Chemotherapy
por: Gabani, Mohanad, et al.
Publicado: (2021) -
Morphine Enhances Doxorubicin-Induced Cardiotoxicity in the Rat
por: Hole, Lisa Drange, et al.
Publicado: (2014) -
The true colors of autophagy in doxorubicin-induced cardiotoxicity
por: Xiao, Bin, et al.
Publicado: (2019)